Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea (RAPID)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by University of Nottingham
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Nottingham Identifier:
First received: August 17, 2012
Last updated: February 25, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)